Introduction to drug utilization research
Wettermark, B
Elseviers, M
Mueller, T
Almarsdottir, AB
Benkő, R
Bennie, M
Iaru, I
Gvozdanović, K
Hoffmann, M
Ivanovska, V
MacBride-Stewart, S
Poluzzi, E
Pont, LG
Blix, HS
Sanfelix-Gimeno, G
Selke, GW
Taxis, K
Petrović, AT
Trečiokienė, I
Vogler, S
- Publisher:
- Wiley
- Publication Type:
- Chapter
- Citation:
- Drug Utilization Research: Methods and Applications,, 2024, 2, pp. 1-13
- Issue Date:
- 2024-01-01
In Progress
Filename | Description | Size | |||
---|---|---|---|---|---|
23923962_16359247190005671.pdf | Published version | 822.07 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is being processed and is not currently available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Wettermark, B | |
dc.contributor.author | Elseviers, M | |
dc.contributor.author | Mueller, T | |
dc.contributor.author | Almarsdottir, AB | |
dc.contributor.author | Benkő, R | |
dc.contributor.author | Bennie, M | |
dc.contributor.author | Iaru, I | |
dc.contributor.author | Gvozdanović, K | |
dc.contributor.author | Hoffmann, M | |
dc.contributor.author | Ivanovska, V | |
dc.contributor.author | MacBride-Stewart, S | |
dc.contributor.author | Poluzzi, E | |
dc.contributor.author | Pont, LG | |
dc.contributor.author | Blix, HS | |
dc.contributor.author | Sanfelix-Gimeno, G | |
dc.contributor.author | Selke, GW | |
dc.contributor.author | Taxis, K | |
dc.contributor.author | Petrović, AT | |
dc.contributor.author | Trečiokienė, I | |
dc.contributor.author | Vogler, S | |
dc.date.accessioned | 2025-02-03T21:55:30Z | |
dc.date.available | 2025-02-03T21:55:30Z | |
dc.date.issued | 2024-01-01 | |
dc.identifier.citation | Drug Utilization Research: Methods and Applications,, 2024, 2, pp. 1-13 | |
dc.identifier.isbn | 9781119911654 | |
dc.identifier.uri | http://hdl.handle.net/10453/184857 | |
dc.description.abstract | Research in drug utilization began to develop in the 1960s. Some pioneering studies focused on assessing differences in drug utilization between countries or regions. Other studies focused on factors influencing the prescribing patterns of physicians. Drug utilization research (DUR) is significantly connected to clinical pharmacology. The original aims of clinical pharmacology were to develop new drugs and to determine the balance between drug benefit and risk in clinical trials. The eclectic nature of drug utilization research requires expertise in a broad range of research methodologies. Qualitative studies are also needed to explore the perceptions of prescribers, dispensers and patients in dealing with medicines. These studies are extremely important to gain a deeper understanding of various phenomena in drug utilization. The nature of the scientific questions and the types of drug utilization studies vary across the world. | |
dc.format.extent | 52 | |
dc.language | en | |
dc.publisher | Wiley | |
dc.relation.ispartof | Drug Utilization Research: Methods and Applications, | |
dc.relation.isbasedon | 10.1002/9781119911685.ch1 | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.title | Introduction to drug utilization research | |
dc.type | Chapter | |
utslib.citation.edition | 2 | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | University of Technology Sydney/UTS Groups | |
pubs.organisational-group | University of Technology Sydney/UTS Groups/UTS Ageing Research Collaborative (UARC) | |
utslib.copyright.status | in_progress | * |
pubs.consider-herdc | false | |
dc.date.updated | 2025-02-03T21:55:29Z | |
pubs.edition | 2 | |
pubs.place-of-publication | USA | |
pubs.publication-status | Published | |
dc.location | USA |
Abstract:
Research in drug utilization began to develop in the 1960s. Some pioneering studies focused on assessing differences in drug utilization between countries or regions. Other studies focused on factors influencing the prescribing patterns of physicians. Drug utilization research (DUR) is significantly connected to clinical pharmacology. The original aims of clinical pharmacology were to develop new drugs and to determine the balance between drug benefit and risk in clinical trials. The eclectic nature of drug utilization research requires expertise in a broad range of research methodologies. Qualitative studies are also needed to explore the perceptions of prescribers, dispensers and patients in dealing with medicines. These studies are extremely important to gain a deeper understanding of various phenomena in drug utilization. The nature of the scientific questions and the types of drug utilization studies vary across the world.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph